Baxter to launch HyQvia in Germany first
This article was originally published in Scrip
Executive Summary
Baxter is to introduce HyQvia, a replacement therapy for adult patients with primary and secondary immunodeficiencies, in select countries in the coming weeks with further EU launches scheduled for 2014 after the European Commission granted marketing authorization for the product.